PLoS ONE,
Journal Year:
2024,
Volume and Issue:
19(9), P. e0310915 - e0310915
Published: Sept. 26, 2024
The
inhibition
of
heat
shock
protein
90
(HSP90),
a
molecular
chaperone,
has
been
proposed
to
be
potential
novel
treatment
strategy
for
Coronavirus
disease
2019
(COVID-19).
In
contrast
other
studies,
our
data
demonstrated
that
RGRN-305,
HSP90
inhibitor,
exacerbated
the
cytopathic
effect
and
did
not
reduce
viral
shedding
in
VeroE6-hTMPRSS2
cells
infected
with
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2).
Likewise
murine
model
SARS-CoV-2,
transgenic
mice
treated
orally
RGRN-305
exhibited
reduced
survival
by
end
experiment
(day
12)
as
14%
(1/7)
survived
compared
63%
(5/8)
those
drug-vehicle.
Animal
weight
was
treatment.
Interestingly,
we
significantly
dampened
inflammatory
response
induced
SARS-CoV-2
spike
human
macrophage-like
(U937)
lung
epithelial
(A549).
Measured
quantitative
real-time
PCR,
mRNA
expression
proinflammatory
cytokines
TNF
,
IL1B
IL6
were
reduced.
Together,
these
suggest
exacerbates
infection
vitro
reduces
but
exhibits
strong
anti-inflammatory
properties.
This
shows
while
may
helpful
‘cytokine
storm’,
it
no
beneficial
impact
on
replication
or
animals
monotherapy.
Further
animal
studies
inhibitors
combination
an
anti-viral
drug
provide
additional
insights
into
its
utility
infections
whether
continue
COVID-19
disease.
Cells,
Journal Year:
2024,
Volume and Issue:
13(2), P. 123 - 123
Published: Jan. 9, 2024
The
COVID-19
pandemic
has
brought
to
the
forefront
intricate
relationship
between
SARS-CoV-2
and
its
impact
on
neurological
complications,
including
potential
links
neurodegenerative
processes,
characterized
by
a
dysfunction
of
protein
quality
control
systems
ER
stress.
This
review
article
explores
role
systems,
such
as
Unfolded
Protein
Response
(UPR),
Endoplasmic
Reticulum-Associated
Degradation
(ERAD),
Ubiquitin–Proteasome
System
(UPS),
autophagy
molecular
chaperones,
in
infection.
Our
hypothesis
suggests
that
produces
stress
exploits
leading
disruption
proteostasis
cannot
be
solved
host
cell.
culminates
cell
death
may
represent
link
neurodegeneration.
Frontiers in Pharmacology,
Journal Year:
2023,
Volume and Issue:
14
Published: Aug. 3, 2023
As
the
outbreak
of
COVID-19
caused
by
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
first
broke
out
in
Hubei
Province,
China,
at
end
2019.
It
has
brought
great
challenges
and
harms
to
global
public
health.
SARS-CoV-2
mainly
affects
lungs
is
manifested
as
pulmonary
disease.
However,
one
biggest
crises
arises
from
emergence
COVID-19-induced
fibrosis.
At
present,
there
are
still
many
questions
about
how
induced
fibrosis
(PF)
occurs
treat
regulate
its
long-term
effects.
In
addition,
an
important
process
fibrosis,
effect
on
epithelial-mesenchymal
transition
(EMT)
may
be
factor
driving
PF.
This
review
summarizes
main
pathogenesis
treatment
mechanisms
related
Starting
with
basic
PF,
such
EMT,
transforming
growth
factor-β
(TGF-β),
fibroblasts
myofibroblasts,
inflammation,
macrophages,
innate
lymphoid
cells,
matrix
metalloproteinases
tissue
inhibitors
metalloproteinases,
hedgehog
pathway
well
Notch
signaling.
Further,
we
highlight
importance
EMT
PF
provide
overview
molecular
mechanisms,
which
will
facilitate
future
research
propose
new
clinical
therapeutic
solutions
for
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: June 27, 2024
Abstract
The
ORF9b
protein,
derived
from
the
nucleocapsid’s
open-reading
frame
in
both
SARS-CoV
and
SARS-CoV-2,
serves
as
an
accessory
protein
crucial
for
viral
immune
evasion
by
inhibiting
innate
response.
Despite
its
significance,
precise
regulatory
mechanisms
underlying
function
remain
elusive.
In
present
study,
we
unveil
that
of
including
emerging
mutant
strains
like
Delta
Omicron,
can
undergo
ubiquitination
at
K67
site
subsequent
degradation
via
proteasome
pathway,
despite
certain
mutations
among
these
strains.
Moreover,
our
investigation
further
uncovers
pivotal
role
translocase
outer
mitochondrial
membrane
70
(TOM70)
a
substrate
receptor,
bridging
with
heat
shock
90
alpha
(HSP90α)
Cullin
5
(CUL5)
to
form
complex.
Within
this
complex,
CUL5
triggers
ORF9b,
acting
host
antiviral
factor,
while
HSP90α
functions
stabilize
it.
Notably,
treatment
HSP90
inhibitors
such
GA
or
17-AAG
accelerates
leading
pronounced
inhibition
SARS-CoV-2
replication.
Single-cell
sequencing
data
revealed
up-regulation
lung
epithelial
cells
COVID-19
patients,
suggesting
potential
mechanism
which
may
exploit
evade
immunity.
Our
study
identifies
CUL5-TOM70-HSP90α
complex
critical
regulator
stability,
shedding
light
on
intricate
host–virus
response
dynamics
offering
promising
avenues
drug
development
against
clinical
settings.
Virologica Sinica,
Journal Year:
2023,
Volume and Issue:
38(6), P. 837 - 850
Published: Oct. 11, 2023
The
recent
emergence
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
caused
serious
harm
to
human
health
and
struck
a
blow
global
economic
development.
Research
on
SARS-CoV-2
has
greatly
benefited
from
the
use
reverse
genetics
systems,
which
have
been
established
artificially
manipulate
viral
genome,
generating
recombinant
reporter
infectious
viruses
or
biosafety
level
(BSL-2)-adapted
non-infectious
replicons
with
desired
modifications.
These
tools
instrumental
in
studying
molecular
biological
characteristics
virus,
investigating
antiviral
therapeutics,
facilitating
development
attenuated
vaccine
candidates.
Here,
we
review
construction
strategies,
development,
applications
systems
for
SARS-CoV-2,
may
be
applied
other
CoVs
as
well.
Microbiology and Molecular Biology Reviews,
Journal Year:
2024,
Volume and Issue:
88(2)
Published: March 27, 2024
SUMMARYHeat
shock
protein
90
(Hsp90)
participates
in
proteostasis
by
facilitating
folding,
activation,
disaggregation,
prevention
of
aggregation,
degradation,
and
protection
against
degradation
various
cellular
proteins.
It
is
highly
conserved
from
bacteria
to
humans.
In
bacteria,
remodeling
Hsp90
involves
collaboration
with
the
Hsp70
molecular
chaperone
cochaperones.
eukaryotes,
folding
more
complex
many
cochaperones
as
well
This
review
focuses
primarily
on
bacterial
highlights
similarities
differences
between
eukaryotic
Hsp90.
Seminal
research
findings
that
elucidate
structure
mechanisms
reactivation
promoted
are
discussed.
Understanding
will
provide
fundamental
insight
into
systems.
Journal of Biological Chemistry,
Journal Year:
2023,
Volume and Issue:
300(1), P. 105536 - 105536
Published: Dec. 12, 2023
Porcine
deltacoronavirus
(PDCoV)
is
an
emerging
enteropathogenic
coronavirus.
It
causes
mortality
in
neonatal
piglets
and
of
growing
concern
because
its
broad
host
range,
including
humans.
To
date,
the
mechanism
PDCoV
infection
remains
poorly
understood.
Here,
based
on
a
genome-wide
CRISPR
screen
PDCoV-infected
cells,
we
found
that
HSP90AB1
(heat
shock
protein
90
alpha
family
class
B1)
promotes
infection.
Knockdown
or
KO
LLC-PK
cells
resulted
significantly
suppressed
Infected
treated
with
HSP90
inhibitors
17-AAG
VER-82576
also
showed
infection,
although
KW-2478,
which
does
not
affect
ATPase
activity
HSP90AB1,
had
no
effect
We
interacts
N,
NS7,
NSP10
proteins
PDCoV.
further
evaluated
interaction
between
N
C-tail
domain
HSP90AB1-interacting
domain.
Further
studies
protects
from
degradation
via
proteasome
pathway.
In
summary,
our
results
reveal
key
role
for
contribute
to
provide
new
targets
antiviral
research.
Drugs and Drug Candidates,
Journal Year:
2025,
Volume and Issue:
4(2), P. 13 - 13
Published: March 28, 2025
The
COVID-19
pandemic,
driven
by
the
high
transmissibility
and
immune
evasion
caused
SARS-CoV-2
its
variants
(e.g.,
Alpha,
Delta,
Omicron),
has
led
to
massive
casualties
worldwide.
As
of
November
2024,
International
Committee
on
Taxonomy
Viruses
(ICTV)
identified
14,690
viral
species
across
3522
genera.
increasing
infectious
resistance
FDA
EMA-approved
antivirals,
such
as
300-fold
efficacy
reduction
in
Nirmatrelvir
against
3CLpro,
highlight
need
for
mutation-stable
likewise
targeting
essential
host
proteins
like
kinases,
heat
shock
proteins,
lipid
metabolism
immunological
pathway
etc.
Unlike
direct-acting
HDAs
reduce
risk
conserved
replication.
proposal
repurposing
current
FDA-approved
drugs
host-directed
antiviral
(HDA)
approach
is
not
new,
Ouabain,
a
sodium-potassium
ATPase
inhibitor
herpes
simplex
virus
(HSV)
Verapamil,
calcium
channel
blocker
influenza
A
(IAV),
name
few.
Given
colossal
potential
HDA
exterminate
infection,
it
been
increasingly
studied
SARS-CoV-2.
This
review
aims
unravel
interaction
between
viruses
human
hosts
their
successfully
proposed
provide
insight
into
an
alternative
treatment
rampant
mutation
benefits,
limitations,
protein-targeted
therapies
prospects
are
also
covered
this
review.